Drug details

Glynase PresTab (micronized glyburide tablets)

type of Antidiabetics, Sulfonylureas

Glynase PresTab (micronized glyburide) is an oral blood-glucose-lowering drug used to treat type 2 diabetes (non-insulin dependent). It is not for treating type 1 diabetes. Glynase PresTab is available in generic form.

The drug is often used to treat Type 2 diabetes .

This drug may have the following side effects:

• nausea,
• blurred vision,
• heartburn,
• joint or muscle pain,
• itching or skin rash
• feeling full,

The following drugs are related to Glynase PresTab, either as a replacement or used together:

• Actos (pioglitazone hydrochloride)
• Kazano (alogliptin and metformin hcl tablets)
• Oseni (alogliptin and pioglitazone tablets)
• Nesina (alogliptin tablets)
• Amaryl Tablets (glimepiride)
• Avandia (rosiglitazone maleate)
• Diabinese (chlorpropamide)
• Cozaar (losartan potassium)
• DiaBeta (glyburide tablets)
• Micronase (glyburide)
• Humalog (insulin lispro (human analog))
• Humalog 75-25 (75-25 insulin lispro suspension and 25 insulin lispro injection)
• Humalog Mix 50-50 (insulin lispro)
• Lantus (insulin glargine [rdna origin] injection)
• Novolin N (insulin isophane)
• Janumet (sitagliptin metformin hcl)
• Kombiglyze XR (saxagliptin and metformin hcl extended-release)
• Lovaza (omega-3-acid ethyl esters)
• Onglyza (saxagliptin tablets)